Search
Showing results for "early lung health"
Urine is an attractive biospecimen for nutritional status and population health surveys. It is an excellent non-invasive alternative to blood for appropriate biomarkers in young children and is suitable for home-based collection, enabling representative collections across a population. However, the bulk of literature in this population is restricted to collection in primary care settings.
The Wal-yan Respiratory Research Centre is a global epicentre for paediatric respiratory research, informing clinical practice and driving a new research agenda for childhood lung health.
The underlying pathogenesis of pediatric obstructive sleep disordered breathing (SDB) and recurrent tonsillitis (RT) are poorly understood but need to be elucidated to develop less invasive treatment and prevention strategies.
This Clinical Puzzle article describes our current knowledge of chronic otitis media and the existing research models for this condition
This research aims to examine subfertility in a population pregnancy cohort, analysing the underlying differences between sub fertile couples who conceive naturally, sub fertile couples who conceive using ART or non-IVF, and fertile couples.
ORIGINS is an interventional cohort study, meaning participants receive timely feedback and an action plan to address any potential abnormalities.
Deborah Lea-Ann Peter Peter Ruth Lehmann Kirkham Jacoby Richmond Thornton AO, MBBS, MSc PhD BA (Hons) MSc MBBS MRCP(UK) FRACP PhD Honorary Emeritus
Adolescence is a period of developmental risk for eating disorders and eating disorder symptoms.
Bioinformatician role as part of the LIFECYCLE team in the Diabetes and Obesity Research Group at The Kids Research Institute Australia
Aboriginal children living in remote communities are at high risk of early and persistent otitis media. Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) are primary pathogens. Vaccines with potential to prevent early OM have not been evaluated in this population. We compared immunogenicity (ELISA and opsonophagocytic activity) of a combination of Synflorix™ (PHiD-CV10, 10 serotypes and protein D of NTHi) and Prevenar13™ (PCV13, 10 serotypes plus 3, 6A, and 19A), with recommended schedules.